With the decreasing cost of direct-acting antivirals in Egypt (from $1,650 [in U.S. dollars] for 12 weeks of sofosbuvir plus daclatasvir in early 2015 to $85 for local generics in 2018), treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results